Tumor reduction was found in nude mice implanted with DU-145 human prostate cancer cells treated with EZN-2968.75 This indicated inhibition of HIF-1α mRNA has potential as a target for cancer therapy. This evidence concerns the gene HIF1A and neoplasm.